Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-10-11
1999-02-23
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544284, 544291, A01N 4354, C07D40100, C07D23972
Patent
active
058744380
ABSTRACT:
The present invention relates to 2,2'-bridged bis-2,4-diaminoquinazolines of the general formula (I): ##STR1## in which the indicated substituents are as defined in the description. The invention also provides processes for the preparation of the compounds of the formula (I), their use for the preparation of drugs, and drugs containing said compounds.
REFERENCES:
patent: 3956495 (1976-05-01), Lacefield et al.
patent: 4734418 (1988-03-01), Yokoyama et al.
Giardina et al., "Synthesis and .alpha..sub.1 -Antagonist . . . Tetraamine Disulfides." Eur. J. Med. Chem. (1997), vol. 32, pp. 9-20.
Abstract of J6 1140-568-A (English language).
Eur.J.Med.Chem. 12, 1977, 325 (English language).
Bullock William
Chisholm Jane C.
Fanelli Richard J.
Feurer Achim
Hubsch Walter
Bayer Aktiengesellschaft
Ngo Tamthom T.
Shah Mukund J.
LandOfFree
2,2'-bridged bis-2,4-diaminoquinazolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,2'-bridged bis-2,4-diaminoquinazolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,2'-bridged bis-2,4-diaminoquinazolines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-307290